DHI
45
2
AAL
48
6
XYL
35
2
PNC
52
-3
MCD
52
-2
CSCO
60
3
EXPE
74
2
WBA
48
-2
ES
48
-2
GLW
48
-4
BIIB
37
9
PSX
34
4
CSX
55
-2
BLK
66
2
AAP
30
3
RIG
60
5
OKE
65
4
LEN
52
4
AEP
43
3
CFG
52
-2
DHI
45
2
AAL
48
6
XYL
35
2
PNC
52
-3
MCD
52
-2
CSCO
60
3
EXPE
74
2
WBA
48
-2
ES
48
-2
GLW
48
-4
BIIB
37
9
PSX
34
4
CSX
55
-2
BLK
66
2
AAP
30
3
RIG
60
5
OKE
65
4
LEN
52
4
AEP
43
3
CFG
52
-2
Financhill
Back

Cue Biopharma 10K Form

Buy
54

CUE
Cue Biopharma

Last Price:
1.37
Seasonality Move:
22.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CUE News And Ratings

See the #1 stock for the next 7 days that we like better than CUE

CUE Financial Statistics

Sales & Book Value

Annual Sales: $5.49M
Cash Flow: $-10M
Price / Cash Flow: 0
Annual Sales: $0.44
Price / Book: 4.14

Profitability

EPS (TTM): -0.98000
Net Income (TTM): $-46.96M
Gross Margin: --
Return on Equity: -132.34%
Return on Assets: -78.3%

Cue Biopharma Earnings Forecast

Key Cue Biopharma Financial Ratios

  • The Research & Development expenses have been 743.21% of Revenue.
  • The Interest Expense is -2.45% of Operating Income.
  • The Net Earning history of CUE is -924.10% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 4 years.

Cue Biopharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CUE
CUSIP: 22978P
Website: cuebiopharma.com

Debt

Debt-to-Equity Ratio: 0.29
Current Ratio: 2.06
Quick Ratio: 1.94

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CUE Technical Analysis vs Fundamental Analysis

Buy
54
Cue Biopharma (CUE) is a Buy

Is Cue Biopharma a Buy or a Sell?

  • Cue Biopharma stock is rated a Buy
    The current Cue Biopharma [CUE] share price is $1.49. The Score for CUE is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.